Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study

NCT03291951 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT03291951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03291951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Completed
Start date
February 23, 2018
Completion date
March 21, 2022
Enrollment
183 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, colon cancer, resistance training